A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Clinical trial NCT00796432 · COMPLETED
Trial details
- NCT number
- NCT00796432
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.